Focused on the manufacturing of breakthrough cell therapies. Their bioreactor with unique properties (controlled shear forces, homogeneity, easy scale-up, etc.) meets the challenges of expanding induced pluripotent stem (iPS) cells.
Mars 2025
FR - Provence-Alpes-Côte d'Azur
TechBio
Medtech - Laboratory PoC